HAVCR2 induces T cell exhaustion in cancer and chronic viral infections, and its expression in monocytes and tumor-associated macrophages is closely associated with higher HCC tumor grade and lower patient survival rates (80). Here, HAVCR2 is linked to hepatocellular carcinoma.